Effect of Yinzhihuang oral solution for neonatal hyperbilirubinemia: A multi-center randomized cotrolled study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10000847

Enrollment

Unknown

Registered

2010-04-18

Start date

2010-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal hyperbilirubinemia

Interventions

Group A:Yinzhihuang Oral Solution and phototherapy

Group B:Phototherapy only

Group C:Phenobarbital and phototherapy

Eligibility

Sex/Gender

All

Age

1 Years to 28 Years

Inclusion criteria

Inclusion criteria: gestational age >=37 weeks, with hyperbilirubinemia, the bilirubin level over 40 percentile

Exclusion criteria

Exclusion criteria: 1. patients who need exchange transfusion; 2. patients with metabolic diseases or biliary tract malformation.

Design outcomes

Primary

Measure	Time frame
the change of bilirubin level;	—

Secondary

Measure	Time frame
phototherapy requirment and duration;side effect of medicine;	—

Countries

China

Contacts

Public ContactLiping Shi

slping2008@yahoo.cn+86 13868172972

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026